London: The World Health Organization (WHO) is set to officially back the use of weight-loss drugs as a treatment for obesity ...

Eli Lilly’s expanding US production and advancing pipeline offset near-term headwinds and support bullish conviction. Read ...

In 2023, experts decided against adding obesity drugs to the World Health Organisation's essential medicines list.

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Kyle Richards’s daughter, Sophia Umansky, shared alarming footage of her hair loss after rapidly losing weight with the help ...

Texas baseball ace Jared Spencer departed Thursday night's game against Auburn with soreness in his pitching arm, Longhorns coach Jim Schlossnagle said. Spencer allowed a home run to Auburn's Ike ...

In an internal memo, the World Health Organization signaled its support for anti-obesity drugs like Wegovy and Zepbound, ...

Eli Lilly on Thursday downplayed CVS Health's decision to drop the company's obesity drug Zepbound from some lists of ...

Q, reporting significant increases in revenue and net income for the three months ended March 31, 2025. Revenue surged to $12 ...

Eli Lilly’s stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound.

Eli Lilly & Co.’s shares saw the biggest one-day drop since 2008 after CVS Health Corp. announced a plan to drop its ...

CVS Health Corp.’s drug-benefits unit negotiated a deal to make Novo Nordisk A/S’s Wegovy more widely available to its ...